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Abstract 
Despite the availability of the human papillomavirus (HPV) vaccine, African American 
women are still at risk for contracting HPV.  This is significant because HPV is one of 
the main risk factors for cervical cancer.  The purpose of this quantitative study was to 
explore the relationship between the use of HPV vaccination for cervical cancer 
prevention and personal history of HPV, reduced access to healthcare, and risky sexual 
behaviors in African American women.  The theoretical framework used for this study 
was the health belief model (HBM).  Two hundred twenty-nine (n=229) African 
American women living in the United States, ages 18-49, who participated in the 2013-
2014 National Health and Nutrition Examination Survey (NHANES) were the sample 
under study.  A univariate analysis was performed to describe the population and obtain 
frequencies and percentages for all covariates.  A bivariate analysis was conducted to 
determine whether there was an association between any of the independent variables and 
the dependent variable.  A multivariable logistic regression was conducted to build a 
predictor model for use of HPV vaccination.  Women between the ages of 18 and 34 
were 7.22 times as likely to receive the HPV vaccine as women aged 35-49 years, and 
this was statistically significant (OR: 7.22; 95% CI: 2.36 – 22.13).  This study can 
contribute to positive social change within the community and public health profession 
through an increased awareness and knowledge of HPV and cervical cancer, especially 
for African American women.  
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Dedication 
Being black in this world certainly comes with its struggles, but I would not trade 
that integral part of my identity for anything!  #BlackGirlMagic is real and has been 
since the beginning of time!  It is however a sad element that we are often plagued with 
disproportionately high incidences and mortality rates for heart disease, breast and 
cervical cancer, sickle cell, fibroids, premature births, STIs/STDs, mental health issues 
and so much more.  It sounds scary because we feel like we are always the target, but 
knowledge is power and for that...this work is dedicated to you!  For our journeys in 
learning to educate ourselves, our communities, and being an advocate for our own 
health equity, health quality, and health disparities is one that will raise alarm and 
awareness.  After all… 
“All knowledge meets an end at the question...Why?” ―Criss Jami, Healology 
Too often we are seen as ‘running but never catching up’ and handed few choices 
and even fewer protections.  But, we must remember that we are strong, worthy, resilient, 
and the greatest gift to mankind.  Thus, our very existence and health is the upmost 
importance because if we don’t take it seriously, who will?  I hope this work inspires you 
and contributes to your insightfulness and exploration of health issues affecting us black 
women.  After all… 
“We do not know a truth without knowing its cause.” ―Aristotle, Nicomacheian 
Ethics, I.1. 
 
 
 
 
 
I have spent my entire academic journey on trying to figure out how I as a public 
health practitioner and researcher can educate and improve health statuses and quality of 
life for black and minority women.  A wise man once said we cannot be informed if the 
information is not better.  So, here’s to learning, educating, and changing headlines.  
After all…  
“I have never felt more confident in myself, more clear on who I am as a 
woman…But I am constantly thinking about my own health.” —Michelle Obama 
Last but certainly not least, this humble work is dedicated to and is a sign of my 
love for all of the strong black men and women leaders and role models in my family, 
circle of networks, and other political, social, philanthropic, and health fields that have 
demonstrated conviction and shown me what it means to be truly authentic.  A special 
heartfelt thank you to those family members, friends, and Sorors of Alpha Kappa Alpha 
Sorority, Incorporated who have seen my potential, called it out, and began addressing 
me as “Dr. Dee”, “Dr. Hanson”, “Dr. Diamond”, or “Dr. Bestie” long before I was given 
this title.  I love you all and I am forever grateful of the unconditional love, support, 
enthusiasm, and encouragement you all have given me!  And to the leaders who are yet to 
come but are experiencing the moments that matter, I see you Kings and Queens…keep 
smiling, stay focused, and don’t ever let anyone dim your light!  
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Section 1: Foundation of the Study and Literature Review 
Introduction 
The human papillomavirus (HPV) is the most common sexually transmitted 
infection (STI) in the United States (Vázquez-Otero et al., 2016; Young et al., 2015).  
HPV is so common that the Centers for Disease Control and Prevention (CDC) stated that 
almost every sexually active person will become infected with HPV at some point in their 
lifetime (CDC, 2017a).  There are two main types of HPV: low-risk (LR-HPV) and high-
risk (HR-HPV).  LR-HPV causes approximately 90% of genital warts and HR-HPV, 
especially HPV-16 and 18, causes more than 70% of cervical cancer cases (CDC, 2017a; 
Winer et al., 2006).  Furthermore, the CDC estimated that each year, HPV will cause 
cancer in 17,000 women (CDC, 2017a).  These statistics reveal a public health issue that 
is more alarming for certain racial/ethnic groups.  Previous researchers have presented 
varying results which have found that African American women who were screened as 
much or at higher rates than Caucasian women still exhibited the highest cervical cancer 
mortality rate (King, Chen, Garza, & Thomas, 2014; Downs Jr., Scarinci, Einstein, 
Collins, & Flowers, 2010). 
This study contributes to positive social change within the community and the 
public health profession.  Individuals and communities will have an increased awareness 
and knowledge about HPV, cervical cancer, the relationship between the two, and the 
importance of receiving the HPV vaccine.  As a result, the dissemination of this 
information by public health practitioners would aid in increased vaccination rates, 
decreased HPV infections, and decreased cervical cancer diagnoses and fatalities, 
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especially among African American women.  This study is unique because it explores the 
relationships between the use of HPV vaccination and personal history of HPV, reduced 
access to healthcare, and sexual behaviors among African American women, ages 18–49, 
in the United States, whereas previous studies have explored this relationship in specific 
geographical locations.  
In Section 1, I present the problem statement and purpose of the study.  Following 
these subsections, I discuss the studies’ research questions and hypotheses, as well as the 
theoretical foundation and nature of the study.  Next, I present a detailed literature search 
strategy and an extensive literature review, including definitions (see Appendix A for 
more information on abbreviations), assumptions, scope, and delimitations.  Lastly, I 
explore the significance of the study and potential contributions to the areas of policy 
and/or practice and a summary of the literature.     
Problem Statement 
HPV is the most commonly STI in the United States with approximately 79 
million Americans currently infected, and 14 million new infections occurring each year 
(Vázquez-Otero et al., 2016; Young et al., 2015).  Half of these infections occur among 
individuals between the ages of 15 and 24.   Despite the availability of the HPV vaccine, 
African American women in the United States, ages 18–49, are still at risk for contracting 
HPV, which causes cancer. 
To date, many studies have been conducted on HPV vaccinations and Pap smear 
screenings and the disparities that exist among African American women compared to 
other racial/ethnic groups.  Although African American women are just as likely or more 
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than likely to have a Pap smear than Caucasian women, they are more likely to die from 
the disease than Caucasian women (Brown, Wilson, Boothe, & Harris, 2011).  Studies 
suggest that African American women are less likely to be educated about the risk of 
HPV and its relationship to cervical cancer compared to women of other racial/ethnic 
groups due to personal history of HPV, reduced access to healthcare, and risky sexual 
behaviors, which can all influence HPV infections (Mullins et al., 2016; Vázquez-Otero 
et al., 2016; Strohl et al., 2015; Okafor, Hu, & Cook, 2015;Mayhew et al., 2014; Laz, 
Rahman, & Berenson, 2012; Wong & Do, 2012; Brown, Wilson, Boothe, & Harris, 2011; 
Dempsey, Cohn, Dalton, & Ruffin, 2011; Downs, Scarinci, Einstein, Collins & Flowers, 
2010; Garner, 2003).  More recently, new research has suggested that African American 
women are infected with strains of cervical cancer-causing HPV subtypes (i.e. 31, 35, 45, 
56, 58, 66 and 68) that the current vaccines do not protect against, which may 
significantly contribute to higher cervical cancer morbidity and mortality rates (Vidal et 
al., 2014). 
Purpose of the Study 
The purpose of this quantitative study was to explore the relationship between the 
use of HPV vaccination and personal history of HPV, reduced access to healthcare, and 
risky sexual behaviors among African American women, ages 18–49, in the United 
States.  The identified independent variables were personal history of HPV, reduced 
access to healthcare, and sexual behavior.  The dependent variable was the use of HPV 
vaccination.  Covariates included in this study were age, marital status, annual household 
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income, educational attainment, and specific risky sexual behaviors.  For the purposes of 
this study, ‘use’ and ‘receipt’ of HPV were used interchangeably.   
Research Questions and Hypotheses 
The following were the research questions and associated hypotheses for this 
study: 
Research Question 1 (RQ1): Is there an association between use of HPV 
vaccination and personal history of HPV among African American women, ages 18–49? 
Null Hypothesis (H01): There is no association between use of HPV vaccination 
and personal history of HPV among African American women, ages 18–49. 
Alternative Hypothesis (Ha1): There is an association between use of HPV 
vaccination and personal history of HPV among African American women, ages 18–49. 
 Dependent Variable: Use of HPV vaccination for cervical cancer prevention 
 Independent Variable: Personal history of HPV  
Research Question 2 (RQ2): Is there an association between use of HPV vaccination 
and reduced access to healthcare among African American women, ages 18–49?  
Null Hypothesis (H02): There is no association between use of HPV vaccination 
and reduced access to healthcare among African American women, ages 18–49.   
Alternative Hypothesis (Ha2): There is an association between use of HPV 
vaccination and reduced access to healthcare among African American women, ages 18–
49.   
 Dependent Variable: Use of HPV vaccination for cervical cancer prevention 
 Independent Variable: Reduced access to healthcare 
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Research Question 3 (RQ3): Is there an association between use of HPV vaccination 
and risky sexual behaviors among African American women, ages 18–49?    
Null Hypothesis (H03): There is no association between use of HPV vaccination 
and risky sexual behaviors among African American women, ages 18–49. 
Alternative Hypothesis (Ha3): There is an association between use of HPV 
vaccination and risky sexual behaviors among African American women, ages 18–49. 
 Dependent Variable: Use of HPV vaccination for cervical cancer prevention 
 Independent Variable: Risky sexual behaviors 
Theoretical Foundation for the Study 
The theoretical framework for this study was based on the health belief model 
(HBM), which is shown in Figures 1 (health belief model components) and 2 (health 
belief model for HPV vaccination).  Developed in the 1950s by social psychologists, 
Hochbaum, Rosenstock, and Kegels, who worked for the United States Public Health 
Services, the HBM is a psychological model that attempts to describe and predict health 
behaviors (Glanz, Rimer, & Lewis, 2002; Rosenstock, 1974).  By focusing on the 
attitudes and beliefs of individuals, the HBM was developed in response to the failure of 
a free tuberculosis health screening program.  Since its inception, the HBM has been 
adapted to explore various long and short-term health behaviors, and most notably, risky 
sexual behaviors and the transmission of HIV/AIDS and other STIs (Glanz, Rimer, & 
Lewis, 2002; Rosenstock, 1974).  Per Conner and Norman (1996), the HBM has been 
applied to a broad range of health behaviors such as “preventive health behaviors, which 
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include health-promoting (e.g. diet, exercise) and health-risk (e.g. smoking) behaviors as 
well as vaccination and contraceptive practices.”   
To date, the HBM has been used by a plethora of studies surrounding HPV and 
cervical cancer, the factors and beliefs that contribute to HPV infection, and the issues 
surrounding cervical cancer prevention (i.e. HPV vaccine, Pap smear screening and 
follow-up) (Brown, Wilson, Boothe & Harris, 2011; Bynum et al., 2011; Hsu et al., 2009; 
Rosenthal et al., 2010).  Research has suggested that health beliefs can influence whether 
an individual will accept and undergo HPV vaccination (Bynum et al., 2011; Rosenthal et 
al., 2010; Hsu et al., 2009).  Furthermore, Rosenstock (1974) believed that participation 
in preventive health behaviors depends on an individual’s perceived susceptibility to 
disease (HPV), severity of health outcomes (cervical cancer morbidity and/or mortality), 
benefits of and barriers (personal history and reduced access to healthcare) to behavior 
engagement, and cues to motivate action (conversations with healthcare providers, an 
increased knowledge about HPV and cervical cancer, and vaccination for cervical cancer 
prevention).  The HBM provides a useful framework for creating prevention and 
intervention programs, which would help improve HPV and cervical cancer knowledge, 
and vaccination initiation and completion rates among African American women (Brown, 
Wilson, Boothe & Harris, 2011).  For the purposes of this study, the core assumption is 
that an individual will take a health-related action (i.e. utilize condoms, participate in 
HPV vaccinations, and become more knowledgeable about HPV and cervical cancer) if 
that individual: 
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1. Feels that a negative health condition/disease/infection, such as HPV, can be 
avoided. 
2. Has a positive expectation that by taking a recommended action, she will 
avoid a negative health condition (i.e. utilizing safe sex practices to avoid 
HPV infection, and receiving the HPV vaccination to protect against cervical 
cancer), 
3. Believes she can successfully take a recommended health action (i.e. utilizing 
safe sex practices comfortably, speaking openly with healthcare providers and 
parents with children, etc.) 
 
 
 
 
 
 
 
 
Figure 1. Health belief model components. 
  
Health Belief Model Components 
Perceived 
Susceptibility 
• An invidual's 
assessment of 
his or her 
chances of 
getting a 
disease/condit
ion. 
Perceived Benefits 
• An individual's 
conclusion as to 
whether the new 
behvior /outcome 
is better than 
what he or she is 
already doing or 
not doing. 
Perceived 
Barriers 
• An 
individual's 
opinion as to 
what will stop 
him or her 
from adopting 
the new 
behavior(s). 
Perceived 
Seriousness 
• An 
individual's 
judgement as 
to the severity 
of the 
disease/condit
ion. 
Modifying 
Variables 
• An 
individual's 
personal 
factors that 
affect whether 
the new 
behavior(s) is 
adopted. 
Cues to Action 
• Those factors 
that will start 
a person on 
the way to 
changing 
behavior(s). 
Self-Efficacy 
• Personal 
belief in one's 
own ability to 
do something. 
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Figure 2. Health belief model for HPV vaccination for cervical cancer prevention. 
Adapted from" Factors influencing medication adherence and hypertension management 
revisited: recent insights from cancer survivors," by M. Morgado and S. Rolo, 2012, 
Hypertension Research, 35(9), p. 894-896. 
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Nature of the Study 
The nature of this study was a quantitative, cross-sectional study design.  This 
allows an observation of data collected at a specific point in time (2013–2014) in order to 
assess the prevalence of HPV vaccination use.  The identified independent variables were 
personal history of HPV, reduced access to healthcare, and risky sexual behaviors.  The 
dependent variable was use of HPV vaccination for cervical cancer prevention.  Age, 
marital status, annual household income, educational attainment, and specific risky 
sexual behaviors were the identified covariates.   
Secondary analysis of the National Health and Nutrition Examination Survey 
(NHANES) archived data were utilized for this study.  NHANES is a recurring, 
population-based survey that was designed to assess the health and nutritional status of 
adults and children in the United States (CDC, 2017c).  The NHANES interview includes 
information on demographics, socioeconomic factors, dietary behaviors, and health-
related questions.  I used demographic, laboratory, and health-related questionnaire data 
files from 2013–2014, as these years provided the most recent data for the variables.  The 
study population was African American women between the ages of 18 and 49.  I 
performed a univariate analysis to describe the population and obtain frequencies and 
percentages for all study variables.  I also conducted a bivariate analysis to determine 
whether there was an association between any of the independent variables and the 
dependent variable.  As a result of the bivariate analysis, the independent variables to be 
included in the multivariable logistic regression, which is conducted to build a predictor 
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model for use of HPV vaccination, were identified.  Adjusted odds ratio (OR) and 95% 
CIs were generated and significant p-values were reported as p < .05.   
Literature Search Strategy 
The following literature review includes my summary of the prevailing research 
on the use of HPV vaccination and personal history of HPV, reduced access to 
healthcare, and risky sexual behaviors of African American women in the United States, 
ages 18–49.  Relevant literature was obtained by using multiple search engines and 
databases, including Google Scholar, PubMed, Google Scholar, MedlinePlus, and the 
Walden University Library system.  Additional data and information were collected 
online from the CDC and the American Cancer Society (ACS).   
The key terms and combinations of search terms I used for the literature review 
included the following: HPV and African American women, cervical cancer and African 
American women, HPV vaccination knowledge/attitudes/beliefs among African American 
women, HPV vaccination, black women and HPV, black women and cervical cancer, 
HPV vaccine and healthcare providers/physicians, HPV vaccine uptake among African 
American women, HPV racial/ethnic disparities, barriers to HPV vaccination, and HPV 
and risky sexual behaviors among African American women.  I ensured the most current 
literature was used by limiting the search to the years 2010 to 2016.  
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Literature Review Related to Key Variables and/or Concepts 
Personal History of HPV 
Use of HPV vaccination and overall knowledge and education about HPV, 
cervical cancer, and the relationship between the two can heavily influence the risk of 
HPV infection, which can then lead to cervical cancer incidence and/or mortality.  
Racial/ethnic disparities are prevalent with respect to cervical cancer screening, 
incidence, and mortality.  For instance, rates of cervical cancer incidence per 100,000 
people for African American women is 9.8 per compared to 7.0 for Caucasian women, 
9.9 for Hispanic women, 9.7 for American Indian and Alaska native women, and, 6.1 for 
Asian and Pacific Islander women (ACS, 2017a).  Cervical cancer mortality rates per 
100,000 people for African American women is 3.9 compared to 2.1 for Caucasian 
women, 2.6 for Hispanic women, 2.8 for American Indian and Alaska native, and 1.7 for 
Asian and Pacific Islander women (ACS, 2017a).  Downs Jr., Scarinci, Einstein, Collins, 
and Flowers (2010) found that although African American women were screened at 
higher rates (88% received at least one Pap smear between 2003 and 2006) than 
Caucasian women, they still exhibited the highest cervical cancer mortality rate 
(4.7/100,000) and the second highest incidence rate (10.8/100,000) (Downs Jr., Scarinci, 
Einstein, Collins, & Flowers, 2010).  The authors suggested that this may be due to poor 
adherence to post-screening follow-up recommendations and dissimilar management of 
abnormal cytology, cervical dysplasia, and cervical cancer in African American women 
despite this group being more likely to complete timely screenings than Caucasian 
women (King, Chen, Garza, & Thomas, 2014).  
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In 2015, Strohl et al. sought to study the knowledge of HPV, cervical cancer, and 
HPV vaccination in African American women living in urban Chicago.  Using a 
quantitative cross-sectional design, 322 surveys were distributed to African American 
women ages 18-70.  These surveys assessed knowledge of HPV, cervical cancer, and the 
HPV vaccine.   Two hundred and forty-two surveys were collected and 215 of the 
subjects met inclusion criteria.  The average knowledge score was 12.3 ± 4.2 (mean ± 
SD) out of a maximum score of 28 (range, 3–23) in which 73% of participants scored 
<65% on the knowledge section of the survey, while educational level (P= .007), 
household income (P=.010) and having a child who had been offered the HPV vaccine 
(P=.041) were associated with adequate (65% accuracy) knowledge scores (Strohl et al., 
2015).  The authors concluded that knowledge of HPV, cervical cancer, and HPV 
vaccination was low in this urban African American adult female population and that 
specific educational health programs are needed to increase awareness among this 
population.  Furthermore, findings from this study were consistent with previous results 
in similar studies that found that African American women were more likely to have less 
knowledge of HPV, cervical cancer, and HPV vaccination.  This study, however, was 
limited as it recruited urban women through convenience sampling.  Because this sample 
was not random, it might not have been representative of all African American women.   
Okafor, Hu, and Cook (2015) sought to determine whether there is a relationship 
between racial/ethnic status and the initiation and completion of the HPV vaccine in 
college women between the ages of 18 and 26 years of age recruited from a large college.  
The women completed surveys that gathered information on sociodemographic 
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characteristics, risky sexual behaviors, gynecological healthcare use, and perception of 
risk of acquiring HPV-associated diseases” (Okafor, Hu, & Cook, 2015).  A total of 53% 
of the women indicated that they had at least one of the three doses of HPV vaccine, and 
among them 70% stated they had completed the full vaccination series of three doses 
(Okafor, Hu, & Cook, 2015).  Black women were significantly less likely to report both 
initiation and completion of the vaccine series than women of other racial/ethnic groups 
(Okafor, Hu, & Cook, 2015).  This study was one of the few that investigated 
racial/ethnic differences in HPV vaccine uptake in college women, and it provided a 5-
year update on rates of initiation and completion of the HPV vaccine series (Okafor, Hu, 
& Cook, 2015).  However, this study was limited as the primary outcome was self-
reported, which has potential for reporting bias in the estimates of HPV vaccine uptake 
(Okafor, Hu, & Cook, 2015).  In addition, other factors, such as socioeconomic status and 
cultural health beliefs, which could have influenced the propensity to become vaccinated, 
were not considered.   
Laz, Rahman and Berenson (2012) conducted a study to provide an update on 
HPV vaccine initiation among women between the ages of 18 and 26.  Data from the 
National Health Interview Survey were used to estimate HPV vaccine coverage and HPV 
vaccine awareness, receipt of the vaccine, number of doses, perceived barriers, and 
relevant socio-demographic variables.  The survey focused on questions related to HPV 
vaccine awareness, receipt of the vaccine, number of doses received, perceived barriers, 
and relevant sociodemographic variables.  The results showed that 77.3% of women ages 
18-26 were not vaccinated.  Out of those women, 68.6% were either not interested in 
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receiving the vaccine or were unsure about receiving the vaccine due to the following 
reasons: felt the vaccine was not needed (39.6%), insufficient knowledge about the 
vaccine (12.7%), concerns about the safety of the vaccine (12.0%), vaccine was not 
recommended by the physician (7.2%), was not sexually active (6.7%), and thought she 
was too old for the vaccine (3.1%) (Laz, Rahman & Berenson, 2012).  Racial/ethnic 
disparities were present as black women were less likely to complete the series of three 
doses of HPV vaccine than Caucasian women (Laz, Rahman & Berenson, 2012).  
Furthermore, women who were uninsured were less likely to receive ≥1 dose (Laz, 
Rahman & Berenson, 2012).  The study had some limitations.  First, the data 
questionnaires were self-reported and may be subject to recall bias due to participants 
giving desirable instead of truthful answers, personal feelings during the time, 
embarrassment, and, questions being misread or misinterpreted.  Next, information on 
vaccine receipt and number of doses received was not confirmed by provider 
immunization records, so there could have been some misclassification (Laz, Rahman & 
Berenson, 2012).  Also, this study did not assess risky sexual behaviors, making it 
impossible to examine the association between risky sexual behaviors and receipt of 
vaccine (Laz, Rahman & Berenson, 2012).  In all, this study contributed to a better 
understanding of racial/ethnic disparities, particularly among African American women, 
as well as additional barriers to initiation and/or completion of the HPV vaccination 
series.   
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Reduced Access to Healthcare 
 Studies have shown that barriers to HPV vaccination include low socioeconomic 
status as measured by income, low educational attainment, lack of insurance, and lack of 
communication between healthcare providers and patients (Strohl et al., 2015; Wong & 
Do, 2012; Dempsey, Cohn, Dalton, & Ruffin, 2011;Downs, Scarinci, Einstein, Collins & 
Flowers, 2010; Garner, 2003).   
Wong and Do (2012) used the 2007 Health Information National Trends Survey 
(HINTS) to examine predictors of physician/patient discussion regarding the HPV 
vaccine in women 18 and older.  The survey asked the following question: “Has a 
healthcare provider such as a doctor or nurse ever talked to you about a cervical cancer 
vaccine or HPV shot?”  Only women who reported ever having heard of the cervical 
cancer vaccine or HPV shot before participating in the survey were asked this question 
(Wong & Do, 2012).  African American women were the highest percentage (26.6%) of 
individuals who had HPV vaccine discussions wither their healthcare providers, 
compared to Hispanic women (17.2%) and Caucasian women (15.8%) (Wong & Do, 
2012).  However, Caucasian women were the most likely (88.7%) to be aware of the 
HPV vaccine, compared to African American women (73.2%) and Hispanic women 
(58.8%) (Wong & Do, 2012).  Furthermore, a statistically significant association was 
observed between lower income and education levels and a lower likelihood of HPV 
vaccine awareness (Wong & Do, 2012).  However, low levels of income and education 
did not affect the likelihood of having discussions about the HPV vaccine with healthcare 
providers (Wong & Do, 2012).    A major limitation of this study was the short time 
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interval between the FDA approval of the quadrivalent vaccine in 2006 and the launch of 
the study in early 2008 (Wong & Do, 2012).  Thus, the small number of respondents who 
reported having the HPV vaccine discussions with their healthcare providers may not be 
reflective of the corresponding situation today (Wong & Do, 2012). 
 Brown, Wilson, Boothe, and Harris (2011) studied the knowledge, attitudes, 
beliefs, and practices of ethnically diverse black women in regard to cervical cancer 
screening.  Haitian, African, English-speaking Caribbean, and African American women 
were recruited from a federally qualified health center.  Focus groups were conducted to 
discuss knowledge of and preventive measures against cervical cancer and HPV, 
facilitators of cervical cancer screening, and barriers to cervical cancer screening (Brown, 
Wilson, Boothe, & Harris, 2011).  Reduced access to healthcare was discussed as it 
relates specifically to the barriers to cervical cancer screening among these groups of 
women.  First, in studies of cervical cancer screening among black women, frequent 
change of residence which would necessitate a change in healthcare provider and lack of 
regular source of care, inability to take time off of work,  lack of trust towards physicians, 
high cost of screening and treatment, family financial obligations, transportation costs, 
language, and citizenship status were major barriers to cervical cancer screening (Bigby, 
Ko, Johnson, David, & Ferrer, 2003; Brown, Wilson, Boothe, & Harris, 2011; Gany, 
Herrera, Avallone, & Changrani, 2006; Ponce et al., 2006; Tsui, Saraiya, Thompson, 
Dey, & Richardson, 2007).  A major limitation of this study was the limited 
generalizability due to the small sample of 44 primarily low-income black women.  Due 
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to this small sample, authors suggested that there is a great need to further explore the 
health-seeking behaviors of this population.   
 Dempsey, Cohn, Dalton, and Ruffin (2011) evaluated characteristics associated 
with HPV vaccine uptake among women between the ages of 19 and 26 seen in primary 
care, university- based clinics.  As an extension from a previous study, clinical visit data 
(medical records and billing data) from the University of Michigan Health System were 
utilized to retrospectively assess various factors associated with HPV vaccine use 
(Dempsey, Cohn, Dalton, & Ruffin, 2011).  Although there were 11,545 women, only 
18% had initiated the three dose vaccine series (Dempsey, Cohn, Dalton, & Ruffin, 
2011).  There was reduced series initiation among older aged women, women who were 
publicly insured and Caucasian women (Dempsey, Cohn, Dalton, & Ruffin, 2011).  On 
the other hand, there was a decrease in series completion among those who were publicly 
insured and African American (Dempsey, Cohn, Dalton, & Ruffin, 2011).  Furthermore, 
results showed disparities by race and insurance worsened over time, which suggested 
that high risk populations were not getting vaccinated (Dempsey, Cohn, Dalton, & 
Ruffin, 2011).  While the population studied was both economically and racially diverse, 
results are based on only one university-based health system located in the State of 
Michigan and may therefore not be generalizable to larger geographic locales (Dempsey, 
Cohn, Dalton, & Ruffin, 2011).  In addition, this sample included a very small number of 
individuals without health insurance.  Young adults have higher rates of being uninsured 
compared to other ages, and as a result, high out-of-pocket costs of HPV vaccines would 
possibly prevent many of these uninsured individuals from being vaccinated (Adams, 
18 
 
 
 
Newacheck, Park, Brindis, & Irwin, 2007; Dempsey, Cohn, Dalton, & Ruffin, 2011; 
Park, Paul Mulye, Adams, Brindis, & Irwin, 2006).   
 Downs Jr., Scarinci, Einstein, Collins, & Flowers (2010) studied populations of 
women in the United States at high risk for cervical cancer and assessed known reasons 
for the current outcome disparities (i.e. perceptions, attitudes, knowledge).  The authors 
also explained ways in which the barriers for HPV vaccination could be reduced and 
strategies for cervical cancer prevention by way of vaccine acceptance and initiation 
could be improved.  The methods for this study were developed by an expert forum 
conducted in 2008 by the Society of Gynecologic Oncologists.  Epidemiological data 
were prepared and discussed by 56 experts in cervical cancer.  One of the main barriers 
discussed was reduced access to healthcare for which five dimensions were described by 
Penchansky and Thomas (1981), including availability (volume and type of services vs. 
location of clientele); accommodation (the ease of obtaining appointments); affordability 
(cost and perceived ability to pay for care); and acceptability (perceptions about practice 
characteristics).  When examining socioeconomic status and race among African 
American and Caucasian women, the authors found that family income was the strongest 
predictor of total healthcare access (Downs Jr., Scarinci, Einstein, Collins, & Flowers, 
2010).  There was also a significant interaction between occupation and race for total 
healthcare access.  This meant that an individual’s occupation significantly predicted 
accessibility, median income by zip code predicted accommodation, and family income 
significantly predicted affordability (Downs Jr., Scarinci, Einstein, Collins, & Flowers, 
2010).  Furthermore, it was noted that impoverished women access healthcare less 
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frequently than mainstream populations.  Therefore, women are utilizing urgent or 
emergent care only, which limits their participation in preventive care such as cervical 
cancer screening (Downs Jr., Scarinci, Einstein, Collins, & Flowers, 2010; Sambamoorthi 
& McAlpine, 2003).  Further discussion and implementation initiatives that focus on 
HPV awareness, knowledge, and vaccination will help eliminate disparities in cervical 
cancer incidence and mortality.  
Risky sexual behaviors 
Rates of STIs continue to increase among African American youth (Raiford, Seth, 
& DiClemente, 2013).  Genital HPV is one of the most common STIs in the United States 
and has the highest rate of infection among college-aged women between the ages of 20 
and 24 (Bynum et al., 2011).  High risk sexual behaviors, including engaging in anal, 
oral, and/or vaginal sex without the use of a condom, multiple sex partners, early age at 
first coitus, and high number of lifetime sexual partners, may contribute to an increase in 
HPV transmission in African American women (Downs Jr., Scarinci, Einstein, Collins, & 
Flowers, 2010; Raiford, Seth, & DiClemente, 2013).    Alcohol and drug use, which can 
lead to the engagement in risky sexual behaviors, has also been studied as a risk factor for 
HPV (Bennett et al., 2009; Bynum et al., 2011).  In addition, the issue of whether 
receiving the HPV vaccine could lead to altered risk perceptions, resulting in the 
engagement of risky sexual behaviors, has also been studied (Mayhew et al., 2014; 
Mullins et al., 2016; Vázquez-Otero et al., 2016). 
Vázquez-Otero et al. (2016) examined whether HPV vaccination was associated 
with inconsistent condom use among college students between the ages of 18 and 26, 
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using the National College Health Assessment-II dataset from fall 2013.  HPV 
vaccination was the primary predictor variable while risky sexual activity was the 
outcome variable (Vázquez-Otero et al., 2016).  There was no association between HPV 
vaccination and inconsistent condom use in any sexual activities, including vaginal, anal, 
or oral sex (Vázquez-Otero et al., 2016).  These findings were consistent with previous 
studies, which also found no differences in the number of sex partners and frequency of 
condom use between individuals who were vaccinated and those who were not 
(Ratanasiripong, 2014).  Additionally, a study by Mayhew et al. (2014) found that there 
were no changes observed in the initiation of sexual activity, number of sexual partners, 
or condom use six months after receiving the HPV vaccine.  One limitation of the study 
by Vázquez-Otero et al. was that the data were self-reported which might have introduced 
social-desirability (participants giving responses based on what they think the researcher 
wants to hear) and non-differential misclassification biases (misinterpretation and/or false 
answers).   
In a similar study, Mullins et al. (2016) sought to examine the association 
between risk perceptions after receiving the HPV vaccine and risky sexual behaviors and 
STI diagnosis over 30 months following vaccination.  Sexually experienced women 
between the ages of 13 and 21 who had completed ≥2 of 4 follow-up visits at 2, 6, 18, 30 
months and including 30 months were enrolled at the time of their first HPV vaccination 
(Mullins et al., 2016).  During each visit, participants were asked about their perceived 
need for safer sexual behaviors and their perceived risk of STIs, other than HPV, as well 
as their risky sexual behaviors (Mullins et al., 2016).  During each visit participants 
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completed surveys that assessed risk perceptions (“perceived need for safer sexual 
behaviors, perceived risk of STIs other than HPV”) and risky sexual behaviors (Mullins 
et al., 2016).  Condom use at last intercourse with main male partner, number of sexual 
partners since last study visit, and STI diagnosis were outcomes.  Scale scores indicated 
that while perceived need for safer sexual behaviors did not change significantly over 
time, scale scores for perceived risk of STIs other than HPV decreased over time 
(p=0.027) (Mullins et al., 2016).  Thus, after 30 months following the HPV vaccination, 
girls perceived themselves to be more at risk of STIs other than HPV than previously 
(Mullins et al., 2016).  A multivariate model demonstrated that while the greater 
perceived need for safer sexual behaviors following vaccination was associated with 
condom use, it was not associated with the number of sexual partners or STI diagnosis 
(Mullins et al., 2016).  In addition, perceived risk of STIs other than HPV was not 
associated with the three variables (Mullins et al., 2016).  However, because there was no 
available information about risk perceptions for participants prior to their receipt of the 
first HPV vaccine dose, changes between pre-and post-vaccination risk perceptions could 
not be examined (Mullin et al., 2016).  The findings of this study suggested that the HPV 
vaccination visit is a vital opportunity for health professionals to reiterate the importance 
of safer sexual behaviors to those who are sexually active, and further, to those who are 
not yet sexually active (Mullins et al., 2016). 
Mayhew et al. (2014) assessed whether adolescent risk perceptions after the first 
vaccine dose predicted subsequent risky sexual behaviors.  Questionnaires were 
completed after receiving the HPV vaccination and then two and six months later by girls 
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between the ages of 13 and 21.  Participants were assessed based on their demographic 
characteristics, knowledge/attitudes about the HPV vaccine, risk perceptions, and risky 
sexual behaviors.  For the 42.5% of girls who were sexually inexperienced, risk 
perceptions at baseline were not associated with subsequent sexual initiation (Mayhew et 
al., 2014).  Girls 16 to 21 who reported lower perceived risk of STI were less likely to 
initiate sex (Mayhew, 2014).  In addition, among all sexually active participants, baseline 
risk perceptions were not associated with subsequent number of sexual partners or 
condom use (Mayhew, 2014).  Finally, risk perceptions after HPV vaccination were not 
associated with riskier sexual behaviors over the subsequent six months of the study 
(Mayhew, 2014).  This study is significant in contributing to the growing evidence that 
receiving the HPV vaccine does not alter risky sexual behaviors among adolescents 
(Mayhew, 2014).  This study was limited as it was conducted within a population 
comprised mainly of low-income black women, which could limit generalizability.  The 
current study will look at African American women from all socioeconomic 
backgrounds.   
Literature Summary 
Literature focusing on personal history of HPV, reduced access to healthcare, and 
risky sexual behaviors, which can all impact the use of HPV vaccination among African 
American women, has been discussed.  Okafor, Hu, and Cook (2015), Laz, Rahman and 
Berenson (2012), and Strohl et al., (2015) presented similar findings and concluded that 
knowledge about HPV and cervical cancer and HPV vaccine initiation and completion 
can influence the risk of HPV infection, which can lead to cervical cancer.  The studies 
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conducted by Brown, Wilson, Boothe and Harris (2011), Dempsey, Cohn, Dalton and 
Ruffin (2011), Downs Jr., Scarinci, Einstein, Collins and Flowers (2010), and Wong & 
Do (2012) and explained that barriers to the utilization of the HPV vaccine include 
limited access to healthcare, low socioeconomic status, low educational attainment, and, 
lack of communication between providers and patients.  Lastly, while engaging in risky 
sexual behaviors can lead to HPV infection, studies by Mayhew et al. (2014), Mullins et 
al. (2016), and Vázquez-Otero et al. (2016) concluded that a change in risky sexual 
behaviors was not associated with vaccine initiation.     
Definitions 
Cancer:  With over 100 types, cancer is the leading cause of death worldwide and 
the second leading cause of death in the United States, causing approximately 8.2 million 
deaths in 2012 (National Cancer Institute [NCI], 2014a; Siegel, Ma, Zou & Jemal, 2014; 
Stewart & Wild, 2014).  In 2017, the ACS predicts approximately 1.7 million new cancer 
cases and over 600,000 deaths (ACS, 2017a).  The International Agency for Research on 
Cancer (IARC) predicted that by the year 2030 there will be 21.4 million new cancer 
cases and 13.2 million cancer deaths globally (ACS, 2015).   Furthermore, in 2017, the 
ACS predicts 12,820 new cases of invasive cervical cancer, resulting in 4,210 deaths 
(ACS, 2017a).   
Cervical cancer:  Cervical cancer is the third most commonly diagnosed cancer in 
women worldwide (Arbyn et al., 2011; Ferlay et al., 2014).  In 2012, there were an 
estimated 528,000 new cases and 266,000 deaths worldwide (Ferlay et al., 2014).  
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According to the National Institutes of Health (NIH), the United States ranks 14
th
 in the 
world for cervical cancer cases (NIH, 2013).  In 2013, there were nearly 250,000 
American women living with cervical cancer (NCI, 2015).   
At the opening of the uterus into the vagina is an organ referred to as the cervix.  
Cervical cancer is usually a slowly-developing disease that is initiated when cancerous 
cells form in tissues of the cervix (NCI, 2014b).  While cervical cancer can form in any 
cervical cell, it primarily develops in those cells lining the surface of the cervix (NCI, 
2014b), squamous and columnar cells (Chen, 2013).  Squamous cell carcinomas account 
for 80 to 90 percent of cervical cancers. Adenocarcinomas develop from columnar cells 
and account for 10 to 12 percent of cervical cancers (Schuiling, & Likis, 2017).  While 
there are multiple risk factors for cervical cancer, HPV is known to be a necessary cause 
(NCI, 2014b). 
 HPV: Derived from the papillomavirus family and consisting of over 200 strains, 
40 of which are transmitted sexually, HPV infects human skin and moist membranes that 
line organs, including the throat, mouth, anus, and cervix (Sushma, Vamsikrishna, Babu 
& Mohanraj, 2014).  Being infected with HPV can also lead to the development of head 
and neck squamous cell carcinoma (HNSCC) (Tan et al., 2015).  HPV is primarily spread 
through skin-to-skin or mucosa-to-mucosa contact, including oral, vaginal, or anal sex 
(Burd, 2003; Schiffman, Castle, Rodriguez & Wachholder, 2007).   
In the early 1980s, a German virologist named Harold zur Hausen was the first to 
discover an association between HPV infection and cervical cancer (Gomez & Santos, 
2007; zur Hausen, 1994).  Thereafter, HPV was recognized as a necessary cause of 
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cervical cancer, causing 99% of cases worldwide (Colombo et al., 2012; Gomez & 
Santos, 2007; Vu, Bui & Le, 2013).   
Today, cervical cancer prevention is conducted using the Papanicolaou (Pap) 
smear.  Created by George Nicholas Papanicolaou, who was credited with explaining the 
physiological and cytological features of the female reproductive system, the Pap smear 
is a method of obtaining cervical epithelial cells (Tan & Tatsumura, 2015).  A pathologist 
then examines these cells to determine if precancerous or cancerous changes have 
occurred within the cervix (Tan & Tatsumura, 2015).  Evidence has shown that 99% of 
cervical cancer deaths are preventable with the use of the Pap smear among regularly 
screened women (DeMay, 2000).  Due to the strong association between HPV and 
cervical cancer, the ACS, the United States Preventive Services Task Force (USPSTF), 
and the American Society for Colposcopy and Cervical Pathology updated their 
recommendations for the early detection of precancerous lesions in the cervix to include 
screening for (HR)-HPV (Saslow et al., 2012).  The revised screening recommendations 
(please see Appendices E and F for more information on USPSTF grades and suggestions 
for practice and cervical cancer screening recommendations) included the use of cytology 
and HR-HPV testing, follow-up (e.g., the management of screen positives and screening 
intervals for screen negatives) of women after screening, the age at which to discontinue 
screening, future considerations regarding HPV testing alone as a primary screening 
approach, and screening strategies for women vaccinated against HPV 16 and 18 
infections (Saslow et al., 2012).   
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While cervical cancer is highly preventable through screening, researchers have 
observed racial/ethnic disparities that persist in cervical cancer screening and deaths.  Per 
the National Center for Health Statistics (NCHS), except for two years, African American 
women have had the highest rates of Pap smear screenings from 1987-2010 (NCHS, 
2013).  In 2010, the Pap smear rate for African American women was almost 78%, 
followed by Hispanic women (73.6%), American Indian/Alaska Native women (73.4%), 
Caucasian women (72.8%), and finally Asian women (68.0%) (data for Native Hawaiian 
or other Pacific Islander were not reported), despite epidemiological data showing that 
African American women are more likely to have cervical cancer and die from it (NCHS, 
2013; Brown, Wilson, Boothe, & Harris, 2011).  On the other hand, the rate of HPV 
vaccination is low in the African American community, and this largely accounts for 
cervical cancer disparities (Strohl et al., 2015).  Several studies have noted that little or no 
access to healthcare, lack of awareness and education about HPV and cervical cancer, 
and risky sexual behaviors also contribute to these disparities (Brown, Wilson, Boothe, & 
Harris, 2011; Downs, Scarinci, Einstein, Collins, & Flowers, 2010; Gelman et al., 2013; 
Scarinci, Litton, Garcés-Palacio, Partridge, & Castle, 2013; Strohl et al., 2015).  
HPV vaccines.  The burden of HPV-related diseases, recent scientific findings of 
viral etiology of several anogenital cancer types, and the development of prophylactic 
vaccines have presented an unprecedented opportunity for cervical cancer prevention on 
a global level (see Appendix D for more information on 2018 recommended 
immunizations).  In addition to cervical cancer screening by use of the Pap smear, there 
are currently three Federal and Drug Administration (FDA) approved prophylactic HPV 
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vaccines: Gardasil (Human Papillomavirus Quadrivalent Vaccine Recombinant; Merck & 
Co., Inc.; approved in 2006), Gardasil 9 (Human Papillomavirus 9-valent Vaccine 
Recombinant; Merck & Co., Inc.; approved in 2014), and Cervarix (Human 
Papillomavirus Bivalent Vaccine, Recombinant; GlaxoSmithKline Biologicals; approved 
in 2009) (ACS, 2017b; FDA, 2017; National Cancer Institute [NCI], 2015; Saslow et al., 
2007).  Gardasil protects against HPV types 6, 11, 16, and 18 (FDA, 2017).  Gardasil 9 
protects against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58 (FDA, 2017).  Lastly, 
Cervarix protects against HPV types 16 and 18 (FDA, 2017).  The goal of these 
prophylactic vaccinations is to reduce the incidence of HPV-related genital disease, 
including cervical, penile, vulvar, vaginal, and anal cancer, and precancerous lesions 
(Saslow et al., 2007).   
Assumptions 
An assumption identified is that because this study utilized a population-based 
dataset to obtain subjects, the external validity of the study is increased.  Secondly, it is 
assumed that the current available vaccines may not adequately protect African American 
women from HPV and cervical cancer due to the strains of HPV found in African 
American women (Vidal et al., 2014).   
Scope and Delimitations 
A quantitative, cross-sectional study design was utilized for this study.  NHANES 
data from 2013–2014, with the inclusion criteria limited to African American women 
between the ages of 18 and 49, were chosen as it contains the most up-to-date 
information reported on the variables to be studied.  As of result of utilizing NHANES, 
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which is a database for secondary data analysis, there were no primary data collections or 
contact with the participants in the study.  Variables utilized in this study were all 
included in NHANES.  Therefore, no other databases were utilized.  Since NHANES is a 
population-based database and only African American women were analyzed, results can 
be generalizable to larger African American populations.  However, this study was 
limited to a quantitative, cross-sectional design and there were no control or comparison 
groups. 
Significance of the Study and Potential for Positive Social Change 
The purpose of this study was to determine the relationship between use of HPV 
vaccination and personal history of HPV, reduced access to healthcare, and risky sexual 
behaviors, controlling for age, marital status, annual household income, and educational 
attainment.  This study is significant as it can provide an avenue to achieve the following 
behavioral and research outcomes: 
 Increased awareness and education about HPV, cervical cancer, and the 
relationship between the two. 
 Increased knowledge and awareness about the importance of receiving the 
HPV vaccination.  
 Increased rates of HPV vaccinations for cervical cancer prevention. 
 Exploration of the HPV vaccine effectiveness in African American 
women. 
This study contributes to positive social change within the community and the public 
health profession through the areas of research, policy, and practice.  First, research will 
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better help individuals and communities understand the HPV vaccination disparities that 
exist among African American women as well as why the current vaccinations are not 
necessarily protective in African American women.  Next, based on the research findings, 
policies and new vaccines can be created to ensure that the most effective and equitable 
practices and education are being executed and relayed to African American women via 
health professionals, physicians, pharmaceutical companies, etc.  Lastly, more 
interventions can be implemented to help with this very preventable disease, resulting in 
a decrease in morbidity and/or mortality of HPV and cervical cancer among African 
American women.   
Summary and Conclusions 
Section 1 intricately described personal history of HPV, reduced access to 
healthcare, and risky sexual behaviors and the literature pertaining to African American 
women.  Additionally, the purpose of the study, the nature of the study, the research 
questions and hypotheses, and a detailed literature review with emphasis on limitations, 
delimitations and assumptions were provided.  This section concluded with a description 
of the positive social change impact of the study.  The subsequent section, Section 2, 
focuses primarily on the research design and rationale, methodology, and threats to 
validity. 
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Section 2: Research Design and Data Collection 
Introduction 
The purpose of this study was to determine the relationships between use of HPV 
vaccination and personal history of HPV, reduced access to healthcare, and risky sexual 
behaviors in African American women, ages 18–49.  This section includes the research 
design and rationale, methodology, and threats to validity.   
Research Design and Rationale 
The identified independent variables were personal history of HPV, reduced 
access to healthcare, and risky sexual behaviors.  The dependent variable was use of HPV 
vaccination for cervical cancer prevention.  The covariates of this study were age, marital 
status, annual household income, and educational attainment, which were controlled for 
using a logistic regression analysis.  I utilized a quantitative, cross-sectional study design 
using secondary NHANES data collected during 2013 and 2014 due to its cost and time 
effectiveness,  I used the data to assess the prevalence of HPV vaccination use and 
selected characteristics of the identified target population previously mentioned.   
Methodology 
In this section I defined how the study was conducted.  I also discussed the study 
population, sampling and sampling procedures used to collect data as described in 
secondary data materials, instrumentation and operationalization of constructs, threats to 
validity, and ethical procedures.    
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Population 
As shown in Appendix C, NHANES unweighted sample size included 10,175 
girls and women of all age ranges.  However, the target population for this study was 
African American women between the ages of 18 and 49.  As a result of this studies’ 
inclusion and exclusion criteria, the sample population was n=229.   
Sampling and Sampling Procedures Used to Collect Data 
 According to the CDC (2013), data from NHANES are not acquired using a 
simple random sample.  Instead, data are collected using a “complex, multistage, 
probability sampling design” that is used to choose participants that are representative of 
the “civilian, non-institutionalized US population” (CDC, 2013, para. 3).  This complex, 
multistage probability sample excludes individuals who reside in nursing homes, are 
members of the armed forces, are institutionalized, and United States nationals living 
abroad (CDC, 2013).  Furthermore, according to the CDC,  
Sample selection for NHANES followed these stages, in order: 1. Selection of 
primary sampling units (PSUs), which are counties or small groups of contiguous 
counties. 2. Selection of segments within PSUs that constitute a block or group of 
blocks containing a cluster of households. 3. Selection of specific households 
within segments. 4. Selection of individuals within a household; see the 
‘‘Household Interview’’ section for more information on sample person selection. 
(2013, para. 3) 
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  I utilized NHANES’ public 2013–2014 datasets and questionnaires. Because 
information pertaining to the access of NHANES datasets is made available for data users 
and researchers throughout the world online, it was not necessary to request permission to 
gain access to the data that I used.  To obtain the data, I completed the following steps, 
which is shown in Figure 3: 
 
 
 
 
 
Figure 3. Accessing NHANES data. 
Inclusion and exclusion criteria.  African American women between the ages of 
18 and 49 are included in this study.  Women who had a positive pregnancy test at the 
time of exam were excluded from this study.     
Sample size.  From 2013–2014, a total of 14,332 persons were selected for 30 
different NHANES survey locations (CDC, 2017c).  Of these, 10,175 people completed 
the interview and 96% (9,813) of these individuals were examined (CDC, 2017c).  From 
this, 229 African American women between the ages of 18 and 49 were used for this 
study. 
Justification for the effect size, alpha level, and power level.  I chose the  
minimum effect size to allow for best external validity since this study was a multistage, 
probability sampling design.  I chose an alpha level of .05 to reduce Type 1 error while 
Identified and 
Searched for 
NHANES Data 
through Desired 
Search Engine          
(Google) 
Selected Desired 
Time Frame      
(2013–2014) 
Selected Desired 
Data                    
(Demographics, 
Laboratory, and 
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Files and 
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Explanations 
Saved Excel 
Files for Data 
Merge into SPSS 
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the power level of .80 reduced Type 2 error, according to Creswell (2013).  I added a 
nonresponse/attrition factor of 10% to account for nonresponse/attrition of selected 
women.  The choice of these figures was made for better external validity and improved 
outcomes from generalization of the study findings, according to Sullivan (2012).  Also, I 
conducted a post hoc power analysis to evaluate the achieved statistical power, please see 
p. 41 of Section 3 for more details.  
Instrumentation and Operationalization of Constructs 
NHANES serves as a great tool for conducting research on the health and 
nutrition of household populations in the United States (CDC, 2016).  NHANES data has 
been used to influence policy, create health programs and services, expand knowledge 
about the health of people in the United States, and improve the health of the United 
States population, such as removing lead from gasoline, establishing national baseline 
estimates for cholesterol, blood pressure, and Hepatitis C, and creating and updating 
pediatric growth charts (CDC, 2016).  I utilized NHANES data for this study to explore 
the many factors that influence use of HPV vaccination for cervical cancer prevention in 
African American women.   
Data have been collected by NHANES since 1959 in three separate time periods: 
The National Health Examination Survey (NHES) era (1959–1970), the periodic and 
population-specific NHANES era (1971–1994), and the continuous NHANES era from 
1999 forward (Zipf, G., Chiappa, M., Porter, KS et al., 2013).  Since 1999, the National 
Center for Health Statistics has released public use data from the continuous NHANES in 
two year cycles (Zipf, G., Chiappa, M., Porter, KS et al., 2013).  As previously 
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mentioned, I utilized data from 2013–2014.  I also used three out of six available 
datasets: demographics (population characteristics), laboratory (disease results), and 
questionnaire (lifestyle behaviors) which all contained relevant variables for this study. 
Operationalization.  The independent variables for this study were personal 
history of HPV, reduced access to healthcare, and risky sexual behaviors.  I defined 
personal history of HPV as ever being told by a doctor one had HPV.  I defined reduced 
access to healthcare by whether an individual was covered by health insurance (“yes” or 
“no”), whether the person had a routine place to go for healthcare (“yes” or “no”), and the 
number of times healthcare had been received over the past year (0, 1–3, and ≥4).  Lastly, 
I defined risky sexual behaviors as if one had ever engaged in sex without use of condom, 
the number of sexual male partners, and coitarche – age at first sexual intercourse.  My 
dependent variable was use of HPV vaccination and was defined by whether an 
individual had ever received a Gardasil or Cervarix HPV vaccination.  This variable was 
categorical (“yes” or “no”). 
The covariates I used in this study were age, marital status, educational 
attainment, and annual household income.  I selected covariates based on statistical, 
social, and biological relationships with HPV.  Age was categorized into the following 
groups: 18–34 and 35–49.  Marital status was categorized as married, widowed, divorced, 
separated, never married, or living with a partner.  Educational attainment was 
categorized as less than 9th grade, Grades 9–12, having attained a high school 
diploma/GED or equivalent, having attended some college or attained an associate’s 
35 
 
 
 
degree, and having completed college or above.  Annual household income was 
categorized as ≤$39,999, $40,000-$59,999, $60,000-$75,999, and ≥$80,000.   
Data analysis plan.  I analyzed data using the Statistical Package for Social 
Sciences® (SPSS) version 21.  The phases of the analysis are shown in Figure 4.  I 
validated data by using the SPSS Data Validation add-on module, which enabled users to 
identify doubtful or unsound cases, variables, and data values, view patterns of missing 
data, and summarize variable distributions, thus allowing users to determine data validity 
and removing or correcting cases prior to analysis (SPSS, 2014).  To ensure accurate and 
effective data analyses, identified variables were recoded and manipulated in line with 
the research questions and data operationalization plans.  Descriptive statistics were 
created and the results were used to create tables and charts.  Univariate (simple 
frequencies and percentages), bivariate (Pearson’s correlation coefficient, Chi-Square 
analyses), and logistic regression analyses were performed to identify relationships, 
measure levels of significance of associations between independent and dependent 
variables, and to reduce statistical errors.  Furthermore, p-values, adjusted odds ratios and 
95% confidence intervals (CIs) were calculated.  A summary of the statistical procedures 
and the relevant questions and hypotheses is provided in Table 1.   
 
 
 
 
 
Figure 4. Data analysis process.  
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Table 1 
Research Questions, Hypotheses, and Appropriate Statistical Procedures 
  
 
 
  
Research Question Hypothesis Variables Statistical Procedure 
Is there an association 
between use of HPV 
vaccination and personal 
history of HPV among 
African American women, 
ages 18–49? 
There is an association between 
use of HPV vaccination and 
personal history of HPV among 
African American women, ages 
18–49. 
DV- HPV vaccination 
use  
 
IV- Personal history of 
HPV  
Bivariate chi-square 
analysis and logistic 
regression  
 
Is there an association 
between use of HPV 
vaccination and reduced 
access to healthcare among 
African American women, 
ages 18–49? 
There is an association between 
use of HPV vaccination and 
reduced access to healthcare 
among African American 
women, ages 18–49.   
DV- HPV vaccination 
use  
 
IV- Reduced access to 
healthcare 
Bivariate chi-square 
analysis and logistic 
regression  
 
Is there an association 
between use of HPV 
vaccination and risky sexual 
behaviors among African 
American women, ages 18–
49?   
There is an association between 
use of HPV vaccination and 
risky sexual behaviors among 
African American women, ages 
18–49. 
DV- HPV vaccination 
use 
 
IV- Risky sexual 
behaviors 
Bivariate chi-square 
analysis and logistic 
regression  
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Research Questions and Hypothesis  
I sought to explore the use of the HPV vaccination for cervical cancer prevention 
in African American women.  The research questions and hypotheses were as follows: 
RQ1: Is there an association between use of HPV vaccination and personal history 
of HPV among African American women, ages 18–49? 
H01: There is no association between use of HPV vaccination and personal history 
of HPV among African American women, ages 18–49. 
H01: There is an association between use of HPV vaccination and personal history 
of HPV among African American women, ages 18–49. 
RQ2: Is there an association between use of HPV vaccination and reduced access to 
healthcare among African American women, ages 18–49?  
H02: There is no association between use of HPV vaccination and reduced access 
to healthcare among African American women, ages 18–49.   
H02:  There is an association between use of HPV vaccination and reduced access 
to healthcare among African American women, ages 18–49.   
RQ3: Is there an association between use of HPV vaccination and risky sexual 
behaviors among African American women, ages 18–49?    
H03: There is no association between use of HPV vaccination and risky sexual 
behaviors among African American women, ages 18–49. 
H03:  There is an association between use of HPV vaccination and risky sexual 
behaviors among African American women, ages 18–49. 
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Threats to Validity 
Cross-sectional study designs are limited in establishing causal relationships and 
directionality (Frankfort-Nachmias & Nachmias, 2008).  In addition, cross-sectional 
study designs are used to describe the pattern of relationship between variables and as a 
result, the elements of manipulation and control that are present in true experimental 
designs are absent in these designs (Frankfort-Nachmias & Nachmias, 2008).   
NHANES oversamples certain population subgroups in efforts to increase the 
reliability and precision of health status indicator estimates for these groups (CDC, 2013).  
Since this study involved the analysis of secondary data, there may be threats to content 
and construct validity of this study.  For example, internal validity was affected due to 
missing data from variables, other unaccounted errors in the data collection itself, and 
response and measurement bias.  In addition, since data from 2013–2014 was studied, 
there may have been a significant change in variables, participant responses, or other 
factors that could have altered or skewed responses throughout the years analyzed.  
Lastly, this study included a small sample size of African American women, which may 
not be the representative of larger African American populations of women. 
Ethical Procedures 
This study did not have any direct contact with human subjects as it involved 
analysis of secondary data collected from 2013 and 2014.  In 2003, the NHANES 
Institutional Review Board (IRB) changed its name to the NCHS Research Ethics Review 
Board (ERB) (CDC, 2017b).  The NCHS Research Ethics Review Board reviewed the 
request for continuation of Protocol #2011- 17- NHANES Survey, which included 2013–
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2014 datasets and was approved (CDC, 2017b).  In regards to the confidentiality of 
participants, CDC ensured all human subjects that all data collected would be held in the 
strictest confidence (CDC, 2017b).  CDC also provided information to participants 
regarding confidentiality of information relative to the Public Health Service Act (42 
USC 242k) (authorizes collection) and Section 308(d) of that law (42 USC 242m), the 
Privacy Act of 1974 (5 USC 552A), and the Confidential Information Protection and 
Statistical Efficiency Act (PL 107-347) (CDC, 2017b).  To ensure complete, safe, and 
secure data, code numbers were assigned in place of names or other personal identifiers 
(CDC, 2017b).  Furthermore, ethical approval was sought and approved by the Walden 
University Institutional Review Board (IRB Approval Number 06-09-17-0568615).   
Dataset treatment post-analysis.  Secondary NHANES data used in this study 
were examined without full disclosure of personal information and identifiers in order to 
avoid an ethical breach.  Any breach in data or release of data would be resolved by 
NHANES.  All data utilized for this study was saved on a Lexar encrypted flash drive, 
and will be properly deleted from the corresponding technological device after five (5) 
years, in pursuant with Walden University IRB guidelines. 
Summary 
In summation, this section discussed the research design (cross-sectional, 
quantitative), rationale and methodology of the study.  The methodology section 
described the study population (African American women ages 18–49 from the United 
States noninstitutionalized population (NHANES 2013–2014), secondary data 
management, sampling and sampling procedures, and instrumentation and 
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operationalization of constructs.  When describing the instrumentation and 
operationalization of constructs, the dependent and independent variables, the data 
collection and management techniques, and the data analysis plan were all described.  
Additionally, this section discussed threats to validity, ethical considerations, and dataset 
treatment post analysis.  The next section, Section 3, presents the results and findings of 
this study.  This section also discusses the period for data collection, the actual 
recruitment and the response rate of participants, and discrepancies in the use of the 
secondary dataset.  Descriptive and demographic characteristics of the sample, basic 
univariate, and bivariate and multivariate analyses are also presented. 
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Section 3: Presentation of the Results and Findings 
Introduction 
The purpose of this quantitative study was to explore the relationship between use 
of HPV vaccination and personal history of HPV, reduced access to healthcare, and risky 
sexual behaviors among African American women, ages 18–49, living in the United 
States.  Section 3 includes results of statistical analysis on data collected from NHANES.  
In this section I provided a description of the timeframe and sample population 
demographics, representativeness of the sample, and univariate characteristics and 
analysis of the sample.  The study results subsection includes the results of the chi-square 
tests for RQ1, RQ2, and RQ3, and the multivariate logistic regression model. 
Data Collection of Secondary Data Set 
Each year, approximately 5,000 individuals of all ages are interviewed in their 
homes and complete the health examination component of the survey, which is conducted 
in a mobile examination center (MEC; CDC, 2017c).  NHANES data files contain 
information pertaining to demographics, diet, examination and laboratory history, and 
questionnaires.  As previously mentioned, I utilized 2013–2014 data as it pertained to 
population characteristics (demographics), disease/infection-related results (laboratory), 
and lifestyle behaviors (questionnaire) to conduct chi-square and logistic regression 
analyses on HPV vaccination, as identified by the research questions of this study.     
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Time Frame and Response Rates 
According to NHANES, data proposals begin 2 years prior to the actual survey 
time frame (see Appendix B for more information on content planning process and data 
release schedule).  Data proposals for 2013–2014 data files launched in 2011.  A total of 
5,172 women (unweighted sample size) were interviewed, which produced a 71.4% 
response rate (please see Appendix C for more information on unweighted response rates 
for NHANES 2013–2014).  However, only 4,982 women (unweighted sample size) were 
examined, producing a 68.8% response rate (please see Appendix C).  For the purposes 
of this study, only 229 African American women were studied.  Due to the lack of 
responses from African American women, many of the data variables were subject to 
missing values.  Although the sample used in this study (229 women) was smaller than 
initially planned, adequate statistical power was achieved (>0.90) due to the high effect 
size detected in the regression analysis (7.227, Table 12, G*Power Calculator) (Erdfelder, 
Faul, & Buchner, 1996). 
Descriptive Demographics of the Sample 
 The sample population was 229 African-American women.  All 229 women 
responded to questions regarding reduced access to healthcare and risky sexual behaviors.  
All respondents were between the ages of 18–49, the average age being 32.50.   
Representativeness of the Sample 
According to the NHANES (CDC, 2017c), the sample for the survey is selected to 
be representative of the United States population of all ages.  In efforts to obtain 
responses from samples that are representative of certain age groups and racial/ethnic 
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groups, NHANES over-samples individuals 60 and older and African American and 
Hispanic populations (CDC, 2017c).  Of the 5,000 households selected for NHANES, 
229 African American women ages 18–49 formed the study sample.   
Study Results 
Univariate Characteristics of the Sample 
 Nearly 60% of women included in this study were between the ages of 18 and 34.  
Fifty-two percent (52.8%) of the women were never married.  Nearly 40% (39.6%) 
attended some college or obtained an associate’s degree, while 16.2% were college 
graduates.  All the women had an annual household income less than or equal to $39,999 
(100%).  Seventy-one percent (71.2%) of the women had health insurance coverage.  
Nearly 90% of the women had a routine place to go for healthcare, and 87.3% had 
received healthcare at least once over the past year.  Eighty percent (80%) of women had 
engaged in some form of risky sexual behavior.  Eighty-six percent (86.4%) of women 
stated they had never been told by a doctor they had HPV, while 83.3% had never 
received the HPV vaccination.  
In this section I displayed the study results for each research question.  To 
determine whether there was an association between use of HPV vaccination and 
personal history of HPV, reduced access to healthcare, and risky sexual behaviors among 
African American women ages 18–49, I conducted chi-square tests.  Table 2 displays the 
demographic and behavioral characteristics of the population.  Table 3 displays the 
distributions of and the chi-square results for population demographics and behavioral 
characteristics by HPV vaccination. Table 4 displays the statistical cross-tabulation for 
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HPV infection by HPV vaccination.  Tables 5-7 display the statistical cross-tabulations 
associated with reduced access to healthcare.  Statistical cross-tabulations between risky 
sexual behaviors and HPV vaccination are displayed in Tables 8-11.  The logistic 
regression of covariates by HPV vaccination is shown in Table 12.  All the results are 
discussed per research question and per table below. 
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Table 2 
 
Univariate Descriptive Analyses of Population Demographics and Behavioral 
Characteristics 
 
N = 229 n % 
Age 
     18–34 
     35–49 
Marital status 
     Married 
     Widowed 
     Divorced 
     Separated 
     Never married 
     Living with partner 
Educational attainment 
     Less than 9th grade 
     Grades 9–12 
     High school graduate/GED or    
     equivalent 
     Some college or Associate’s degree 
     College graduate or above 
Annual household income 
     ≤ $39,999 
Health insurance coverage 
     Yes 
     No 
Routine place to go for healthcare 
     Yes 
     No, there is no place to go 
Number of times healthcare has been received in the 
last year 
     0 
     1–3 
     ≥4 
 
134 
95 
 
49 
2 
25 
5 
121 
27 
 
6 
38 
54 
 
88 
36 
 
227 
 
163 
66 
 
205 
24 
 
 
29 
154 
46 
 
58.5 
41.5 
 
21.4 
.9 
10.9 
2.2 
52.8 
11.8 
 
2.8 
17.1 
24.3 
 
39.6 
16.2 
 
100 
 
71.2 
28.8 
 
89.5 
10.5 
 
 
12.7 
67.2 
20.1 
Ever engaged in risky sexual behaviors 
     Yes 
     No 
Ever been told by a doctor you had HPV 
     Positive 
     Negative 
Ever received HPV vaccination 
     Yes 
     No 
 
183 
46 
 
 
6 
38 
37 
185 
 
80.0 
20.0 
 
 
13.6 
86.4 
16.7 
83.3 
*Note: Those with missing information were excluded from percentages. 
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Table 3 
Distribution of Population Demographics and Behavioral Characteristics and Statistical 
Cross-tabulations for them by HPV Vaccination 
 
 Received HPV Vaccination  
N = 229 
 
Yes 
      n                       % 
No 
 n                %       
Chi-square 
p-value 
Age 
18–34 
35–49 
Marital status 
Married 
Widowed 
Divorced 
Separated 
Never married 
Living with partner 
Educational attainment 
Less than 9th grade 
Grades 9–12 
High school graduate/GED or 
equivalent 
Some college or Associate’s 
degree 
College graduate or above 
Annual household income 
≤ $39,999 
Health insurance coverage 
Yes 
No 
Routine place to go for healthcare 
Yes 
No, there is no place to go 
Number of times healthcare has been 
received in the last year 
0 
1–3 
≥4 
 
 
33 
4 
 
4 
0 
3 
1 
27 
2 
 
2 
8 
5 
 
19 
3 
 
37 
 
26 
11 
 
33 
4 
 
 
4 
21 
12 
 
89.0 
11.0 
 
10.8 
0.0 
8.1 
2.7 
73.0 
5.4 
 
5.4 
21.6 
13.5 
 
51.4 
8.1 
 
100 
 
70.0 
30.0 
 
89.2 
10.8 
 
 
11.0 
57.0 
32.0 
 
98 
87 
 
44 
2 
22 
4 
91 
22 
 
3 
30 
47 
 
66 
32 
 
183 
 
132 
53 
 
165 
20 
 
 
24 
129 
32 
 
53.0 
47.0 
 
23.7 
1.0 
12.0 
2.2 
49.1 
12.0 
 
1.6 
17 
26.4 
 
37 
18 
 
100 
 
71.3 
28.7 
 
89.2 
10.8 
 
 
13.0 
70.0 
17.0 
 
<.0001 
 
 
.173 
 
 
 
 
 
 
.102 
 
 
 
 
 
 
NR 
 
.895 
 
 
1.00 
 
 
 
.108 
Ever engaged in risky sexual behaviors 
Yes 
No 
Ever been told by a doctor you had HPV 
Yes 
No 
 
30 
7 
 
0 
10 
 
81.0 
19.0 
 
0 
100 
 
148 
37 
 
5 
28 
 
80.0 
20.0 
 
15 
85 
 
.880 
 
 
.190 
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RQ1: Is there an association between use of HPV vaccination and personal 
history of HPV among African American women ages 18–49?   
Nearly 12% (11.6%) of the women in the sample had a history of HPV.  About 
15% (15.2 %) of those who did not receive HPV vaccine had a history HPV.  Having 
HPV was not significantly associated with HPV vaccination among African American 
women ages 18–49 in the United States (χ2=1.715, p=0.190), which is shown in Tables 3 
and 4.  As a result, there was not sufficient evidence to reject the claim that there is no 
association between use of HPV vaccination and personal history of HPV among African 
American women, ages 18–49.  This implies that personal history of HPV among African 
American women does not impact HPV vaccination.    
Table 4 
Statistical Cross-tabulation for HPV Infection by HPV Vaccination 
Received HPV vaccine * Ever told by doctor you had HPV Cross-tabulation 
 Ever told by doctor you had HPV Total 
               Yes                  No 
Received HPV vaccine 
Yes 
Count 0 10 10 
% within Received HPV 
vaccine 
0.0 100 100 
No 
Count 5 28 33 
% within Received HPV 
vaccine 
15.2 84.8 100 
Total 
Count 5 38 43 
% within Received HPV 
vaccine 
11.6 88.4 100 
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RQ2: Is there an association between use of HPV vaccination and reduced access to 
healthcare among African American women ages 18–49?  
About seventy one percent (71.2%) of women were covered by health insurance, 
while 11.7% of those covered by health insurance received the HPV vaccine.  Health 
insurance coverage was not significantly associated with HPV vaccination among 
African American women ages 18–49 in the United States (χ2=0.018, p=0.895), which is 
shown in Tables 3 and 5.  The results suggest that insurance status does not impact HPV 
vaccination.  Next, having a routine place to go for healthcare was not significantly 
associated with HPV vaccination among African American women ages 18–49 in the 
United States (χ2=0.000, p=1.000), which is shown in Tables 3 and 6.  The results suggest 
that having a routine place to go for healthcare does not impact HPV vaccination.  About 
89% (89.2%) of the patients had a routine place to go for healthcare, while 10.8% of 
women had no routine place to go for healthcare.  Lastly, receiving healthcare in the last 
year was not significantly associated with HPV vaccination among African American 
women ages 18–49 in the United States (χ2=0.018, p=4.45), which is shown in Tables 
3and 7.  More than 12% (12.6%) of women had not received any healthcare within the 
last year, while 67.6% of women received healthcare 1–3 times last year.  Due to the 
findings, there is not sufficient evidence to reject the claim that there is no association 
between use of HPV vaccination and reduced access to healthcare among African 
American women ages 18–49 in the United States.   
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Table 5 
Statistical Cross-tabulation for Health Insurance Coverage by HPV Vaccination 
Crosstab 
 Covered by health insurance? Total 
              Yes                 No 
Received HPV 
vaccine 
Yes 
Count 26 11 37 
% within Received 
HPV vaccine 
70.3% 29.7% 100.0% 
No 
Count 132 53 185 
% within Received 
HPV vaccine 
71.4% 28.6% 100.0% 
Total 
Count 158 64 222 
% within Received 
HPV vaccine 
71.2% 28.8% 100.0% 
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Table 6 
Statistical Cross-tabulation for Routine Healthcare Place by HPV Vaccination 
Crosstab 
 Routine place to go for healthcare Total 
                Yes     There is no 
place 
Received HPV 
vaccine 
Yes 
Count 33 4 37 
% within Received HPV 
vaccine 
89.2% 10.8% 100.0% 
No 
Count 165 20 185 
% within Received HPV 
vaccine 
89.2% 10.8% 100.0% 
Total 
Count 198 24 222 
% within Received HPV 
vaccine 
89.2% 10.8% 100.0% 
    
 
 
 
 
 
 
 
 
 
 
 
51 
 
 
 
Table 7 
Statistical Cross-tabulation for Healthcare Received by HPV Vaccination 
 
RQ3: Is there an association between use of HPV vaccination and risky 
sexual behaviors among African American women, ages 18–49?    
Engaging in risky sexual behavior was not significantly associated with HPV 
vaccination among African American women ages 18–49 in the United States (χ2=0.023, 
p=0.880), which is shown in Tables 3 and 8.  The results suggest that engaging in risky 
sexual behaviors does not impact HPV vaccination.  To further describe data, analyses 
were conducted on individual variables that make up risky sexual behaviors: condom use, 
coitarche, and number of male sexual partners, and are shown in Tables 9-11.  Condom 
use was not significantly associated with HPV vaccination among African American 
women ages 18–49 in the United States (χ2=0.284, p=0.868), which is shown in Tables 3 
Crosstab 
 # of times healthcare received in last year Total 
             0      1–3          ≥4 
Received HPV vaccine 
Yes 
Count 4 21 12 37 
% within Received HPV 
vaccine 
10.8% 56.8% 32.4% 100.0% 
No 
Count 24 129 32 185 
% within Received HPV 
vaccine 
13.0% 69.7% 17.3% 100.0% 
Total 
Count 28 150 44 222 
% within Received HPV 
vaccine 
12.6% 67.6% 19.8% 100.0% 
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and 9.  These results suggest that having sex without the use of condom does not impact 
HPV vaccination.  Coitarche, which is shown in Tables 3 and 10, was not significantly 
associated with HPV vaccination among African American women ages 18–49 in the 
United States (χ2=0.985, p=0.611).   These results suggest that the age at which a woman 
has sex for the first time does not impact HPV vaccination.  Lastly, number of male 
sexual partners, which is shown in Tables 3 and 11, was not significantly associated with 
HPV vaccination among African American women ages 18–49 in the United States 
(χ2=1.433, p=0.489).  Based on findings, there is not sufficient evidence to reject the 
claim that there is no association between use of HPV vaccination and risky sexual 
behavior among African American women ages 18–49.   
 
Table 8 
 
Statistical Cross-tabulation for Risky Sexual Behaviors by HPV Vaccination 
 
Crosstab 
 Risky sexual behavior Total 
Yes                  No          
 
Received HPV vaccine 
Yes 
 
No 
Count 30 7 37 
% of Total 13.5% 3.1% 16.6% 
Count 148 37 185 
% of Total 66.6% 16.7% 83.3% 
Total 
Count 178 44 222 
% of Total 80.2% 19.8% 100% 
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Table 9 
 
Statistical Cross-tabulation for Condom Use by HPV Vaccination 
Crosstab 
 Ever received HPV vaccine Total 
Yes No 
# of times you had sex 
without the use of a 
condom within the past 
year 
Never 
Count 3 11 14 
% of Total 4.7% 17.2% 21.9% 
Inconsistent 
Count 4 23 27 
% of Total 6.2% 35.9% 42.2% 
Always 
Count 4 19 23 
% of Total 6.2% 29.7% 35.9% 
Total 
Count 11 53 64 
% of Total 17.2% 82.8% 100.0% 
 
Table 10 
 
Statistical Cross-tabulation for Coitarche by HPV Vaccination 
Crosstab 
 Ever received HPV vaccine Total 
Yes No 
How old when you first 
had sex 
13 or younger 
Count 1 9 10 
% of Total 1.2% 10.5% 11.6% 
14-17 
Count 11 35 46 
% of Total 12.8% 40.7% 53.5% 
greater than or 
equal to 18 
Count 6 24 30 
% of Total 7.0% 27.9% 34.9% 
Total 
Count 18 68 86 
% of Total 20.9% 79.1% 100.0% 
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Table 11 
 
Statistical Cross-tabulation for Number of Male Sexual Partners by HPV Vaccination 
Crosstab 
 Ever received HPV vaccine Total 
               Yes                 No 
# of Male Sexual 
Partners in Lifetime 
1-5 
Count 4 19 23 
% of Total 7.7% 36.5% 44.2% 
6-10 
Count 5 11 16 
% of Total 9.6% 21.2% 30.8% 
Greater than or Equal to 11 
Count 2 11 13 
% of Total 3.8% 21.2% 25.0% 
Total 
Count 11 41 52 
% of Total 21.2% 78.8% 100.0% 
 
Logistic Regression 
Table 12 displays the logistic regression of HPV vaccination by Covariates.  
Variables controlled for were age, marital status, educational attainment, and income.  
After adjustments, marital status, educational attainment, and income were not 
statistically significant.  However, age was statistically significant.  Women between the 
ages of 18 and 34 were 7.22 times as likely to receive the HPV vaccine as women aged 
35–49 years (OR: 7.22; 95% CI: 2.36 – 22.13).  Confidence intervals were relatively wide 
possibly due to the small sample size of this study.   
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Table 12 
Logistic Regression of HPV Vaccination by Covariates 
 HPV Vaccination 
N = 229 OR 95% CI               
Age 
18–34 
35–49 
 
7.227 
Ref 
 
(2.360 – 22.133) 
Ref 
Marital Status 
     Married 
     Not Married 
 
0.751 
Ref 
 
(0.228 – 2.474) 
Ref 
 
Educational attainment 
     Less than 9th grade 
     Grades 9–12 
     High school graduate/GED or    
     equivalent 
     Some college or Associate’s degree 
     College graduate or above 
 
Ref 
0.552 
0.193 
 
0.559 
0.212 
 
Ref 
(0.070 – 4.350) 
(0.023 – 1.596) 
 
(0.078 – 3.989) 
(0.022 – 2.028) 
 
Income 
     ≤ $39,999 
     Greater than or equal to $39,999 
 
>999.999 
Ref 
 
(<.0001 – >999.999) 
Ref 
 
Summary 
In conclusion, there is no association between use of HPV vaccination and 
personal history of HPV, reduced access to healthcare, and risky sexual behaviors among 
African American women in the United States between the ages of 18 and 49.  However, 
there was a statistically significant association between age and receipt of HPV 
vaccination with women aged 18–34 being more than seven times as likely as women 
aged 35–49 to have received the vaccination (OR: 7.22; 95% CI: 2.36 – 22.13).  Section 4 
serves as an overview of the interpretations, limitations, recommendation, and 
conclusions that are relevant to this doctoral study.  A comparison of findings to relevant 
literature is also provided in Section 4. 
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Section 4: Application to Professional Practice and Implications for Social Change 
Introduction 
The purpose of this quantitative study was to explore the relationship between the 
receipt of HPV vaccination for cervical cancer prevention and personal history of HPV, 
reduced access to healthcare, and risky sexual behaviors in African American women 
ages 18–49.  Overall there was no association between receipt of HPV vaccination and 
any of these variables.  However, there was a statistically significant association between 
receipt of HPV vaccination and age.  This section includes an interpretation of the 
findings, limitations of the study, recommendations for further study, and implications for 
professional practice positive social change.  
Interpretation of the Findings 
The analyses of the NHANES data indicated no significant associations between 
receipt of HPV vaccination and personal history of HPV, reduced access to healthcare, 
risky sexual behaviors, and most of the covariates investigated (i.e. marital status, 
educational attainment, and annual household income).  In the following subsection, I 
compared findings to the literature and discussed this study’s significant result, age.  
Findings to Literature 
Personal history of HPV.  In 2015, Strohl et al. sought to study the knowledge of 
HPV, cervical cancer, and HPV vaccination in African American women living in urban 
Chicago.  The authors concluded that knowledge of HPV, cervical cancer, and HPV 
vaccination was low in this population.  Laz, Rahman and Berenson (2012) conducted a 
study to provide an update on HPV vaccine initiation among women between the ages of 
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18 and 26.  The results showed that 77.3% of the women were not vaccinated.  Lastly, 
Okafor, Hu and Cook (2015) sought to determine the association between racial/ethnic 
status and uptake and completion of the HPV vaccine series in college women.  This 
study also found low initiation of the HPV vaccination among black women.  While this 
current study did not study explore knowledge of HPV, cervical cancer, and HPV 
vaccination, it did show that women between the ages of 18 and 34 were 7.22 times as 
likely to receive the HPV vaccine as women aged 35–49 years (OR: 7.22; 95% CI: 2.36 – 
22.13)..  
Reduced access to healthcare.  Wong and Do (2012) used the 2007 Health 
Information National Trends Survey (HINTS) to examine predictors of physician/patient 
discussion regarding the HPV vaccine in women 18 and older.  The authors found a 
statistically significant association between lower income and education levels and a 
lower likelihood of HPV vaccine awareness.  The current study did not find a statistically 
significant association between lower income and education level and a lower likelihood 
of HPV vaccine awareness.  Brown, Wilson, Boothe and Harris (2011) studied the 
knowledge, attitudes, beliefs, and practices of ethnically diverse black women regarding 
cervical cancer screening and found that reduced access to healthcare was a major barrier 
to receiving the HPV vaccination.  In the current study, 71% of women had health 
insurance, nearly 90% of women had a routine place to go for healthcare, and 67% of 
women had received healthcare 1–3 times in the last year.  While reduced access to 
healthcare was not statistically significant, these results show that women in this sample 
do have access to healthcare and do see healthcare providers often.  It could be further 
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suggested that health is important to these women despite the health outcomes often 
associated with this population compared to women of other racial/ethnic groups.  
Dempsey, Cohn, Dalton and Ruffin (2011) evaluated characteristics associated with HPV 
vaccine uptake among women between the ages of 19 and 26 seen in primary care, 
university-based clinics.  One major finding of this study was that young adults had 
higher rates of being uninsured compared to other ages. 
Risky sexual behaviors.  Vázquez-Otero et al. (2016) examined whether HPV 
vaccination was associated with inconsistent condom use among college students 
between the ages of 18 and 26.  The authors found no association between HPV 
vaccination and inconsistent condom use during vaginal, anal, or oral sex (Vázquez-
Otero et al., 2016).  These findings were consistent with previous studies, which also 
found no differences in the number of sex partners and frequency of condom use between 
individuals who were vaccinated and those who were not (Ratanasiripong, 2014).  In a 
similar study, Mullins et al. (2016) sought to examine the association between risk 
perceptions after receiving the HPV vaccine and risky sexual behaviors and STI 
diagnosis over 30 months following vaccination.  The authors found that while the 
greater perceived need for safer sexual behaviors following vaccination was associated 
with condom use, it was not associated with the number of sexual partners or STI 
diagnosis (Mullins et al., 2016).  Lastly, Mayhew et al. (2014) assessed whether 
adolescent risk perceptions after the first vaccine dose predicted subsequent risky sexual 
behaviors and found that receiving the HPV vaccine did not alter risky sexual behaviors 
among adolescents.  Similar to these studies, the current study found that engaging in 
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risky sexual behaviors was not statistically associated with receiving the HPV 
vaccination.   
Age.  Age was the only statistically significant factor in the current study.  
Women between the ages of 18 and 34 were 7.22 times as likely to receive the HPV 
vaccine compared to women aged 35–49 years (OR: 7.22; 95% CI: 2.36 – 22.13).  
Several studies also showed that age was statistically significant, p < .05, regardless of 
racial/ethnic group (Laz, Rahman, & Berenson, 2012; Okafor, Hu, & Cook, 2015; Wong 
& Do, 2012).  These studies also showed that women who were middle aged were less 
likely to be aware of and knowledgeable of the HPV vaccine and had lower vaccine 
intake and completion rates compared to women of younger age groups.  However, when 
stratified by race/ethnicity, black women were less likely to be aware of the HPV vaccine 
and less likely to be vaccinated.  These study results suggest that it is important that 
young women be continuously targeted for HPV and cervical cancer prevention.  This is 
especially vital due to the fact that many study results showed that as women become 
older, they are either less likely to be vaccinated, less likely to initiate and/or complete 
the recommended vaccine series, or less likely to be knowledgeable regarding HPV, 
cervical cancer, and the HPV vaccine (Okafor, Hu, & Cook, 2015; Strohl et al., 2015; 
Laz, Rahman, & Berenson, 2012).  
Limitations of the Study 
As previously mentioned, in this study there was a lack of female African 
American respondents, which is consistent with similar studies that had a small sample 
size and much missing data (Brown, Wilson, Boothe, & Harris; Okafor, Hu, & Cook, 
60 
 
 
 
2015; Strohl et al., 2015; Wong & Do, 2012).  As a result of the small sample size, there 
was only one significant variable, age, when regression analysis was conducted.  Next, 
personal history of HPV may not have been accurately captured due to self-reporting.  
Furthermore, it would have been interesting to know how many African American 
women died as a result of cervical cancer, and the rate at which African American 
women receive all three recommended doses of the HPV vaccine and follow the Pap 
smear guidelines but are still infected with HPV.  However, NHANES does not currently 
provide this information.   
According to current studies, there may be a relationship between alcohol 
consumption and persistent HPV (Schabath et al., 2014; Weiderpass et al., 2001).  
However, the current study was not able to analyze this variable due to missing data.  
Smoking is another factor linked to the potential development of HPV infection due to 
the carcinogens found in cigarette smoke which are capable of affecting multiple body 
organs, parts, and functions (Schmotzer, 2009; Menard, 2008).  In fact, cigarette smoke 
metabolites and carcinogens have been found in the cells that line the cervix among 
women who smoke (Myatt, 2013). However, smoking was not included in the analysis of 
the current study due to the large amount of missing data. Lastly, parity was not analyzed 
in the current study due to the unavailability of this variable in NHANES (Opara & Zaidi, 
2007).  Parity has been shown to increase the risk of developing cancer following an HR-
HPV infection (Borna, Tabassum, Jahan, Munshi & Unnesa, 2015).   
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Recommendations 
Given the small sample size of the current study, there is a need to conduct an 
additional study that would recruit larger African American female populations.  It would 
be also helpful to assess other racial/ethnic groups to better capture the disparities that 
exist regarding use of HPV vaccination.  There is also a great need to further explore 
other health behaviors of African American women; especially because they are screened 
for cervical cancer as much as or more than Caucasian women but still die sooner.  As 
previously mentioned, African American women who are vaccinated with Gardasil may 
not be protected against HPV (Vidal et al., 2014).  A recommendation to utilize the Gene-
Eden-VIR antiviral treatment, which has been noted as a safe and effective treatment 
against HPV in African American women, has been clinically proven to reduce HPV 
symptoms (Polansky & Itzkovitz, 2013).  More education to the public and to African 
American women and clinical studies are needed to determine if this treatment is an 
alternative to the HPV vaccines that currently do not protect African American women 
from HPV infections.     
Because age was the significant result in the current study with women aged 18–
34 much more likely to receive HPV vaccination than 35–49 year olds, it would be 
beneficial for public health practitioners and physicians to conduct effective outreach to 
African American women between the ages of 18 and 34.  Not only are African 
American women in this age range at risk for not receiving HPV vaccination, but they 
have the ability to influence other social and personal groups to receive and complete 
HPV vaccination.  Lastly, it is extremely important that regardless of age, African 
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American women continuously encourage one another to get vaccinated and be 
compliant with screening recommendations for cervical cancer.  Furthermore, it is 
necessary for public health practitioners to conduct outreach that is targeted towards 
African American women and to ensure that HPV and cervical cancer are discussed at 
healthcare visits.  These outreach and education efforts can assist with increased 
knowledge and awareness of HPV and cervical cancer and the importance of still 
receiving the HPV vaccine despite current conversations and new studies surrounding the 
vaccine’s ineffectiveness in African American women (i.e. an African American woman 
may feel that if the vaccine does not protect against the strains of HPV found in African 
American women, there is no benefit in vaccine intake and/or completion.   
 While the current study did include analysis of covariates analyzed in other 
studies, there were additional variables that could not be investigated.  Alcohol 
consumption, tobacco consumption, and parity were not studied and should be further 
analyzed in future studies.     
Implications for Professional Practice and Social Change 
Bridging the gap between research, policy, and practice to improve public health 
and quality of life, and ultimately to affect positive social change, is essential.  Additional 
research is needed to address why the current HPV vaccines are protective in certain 
racial/ethnic groups and any biological, genetic make-up, or underlying factors that may 
explain this anomaly.  Furthermore, public health professionals and healthcare providers 
are needed to assist with initiating conversations in the African American community 
related to HPV and cervical cancer prevention.  In terms of policy, there are currently 
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three states that require the HPV vaccine as a school requirement (Schwartz & Easterling, 
2015).  According to researchers, when children are receiving their preadolescent 
vaccines is a great opportunity for children to be administered the HPV vaccine.  If there 
were laws mandating that schools nationwide make it a requirement for all children to 
receive the HPV vaccine, this could perhaps further educate parents and encourage them 
to receive the vaccine.          
The current study can contribute to positive social change within the community 
and the public health profession.  If age impacts vaccination knowledge and decisions, it 
is important that women especially of certain age groups be educated.  In fact, a study by 
Watts et al. (2009) highlighted the significance of vaccine knowledge in a wide range of 
age groups among women.  The authors examined attitudes regarding HPV vaccination 
in Latina and non-Latina women between the ages of 18 and 55 and found that the most 
common barriers to receiving the HPV vaccine were inadequate knowledge about the 
vaccine and the belief among mothers that their daughter did not have any risk factors for 
HPV infection.  As a result, that study highlighted the importance of building a 
foundation of knowledge in individuals who are at-risk and to their caretakers and role 
models (i.e. mothers, grandmothers, friends, aunts, health advocates, teachers, etc.) who 
may provide the path to vaccination for all. 
Given the prevalence of HPV infection and the cervical cancer mortality in the 
African American community, this study raises critical concerns on the need for 
improved education and outreach in this community.  Future targeted public health 
education interventions should include partnerships with trusted community 
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organizations, such as schools, community-based clinics, churches, and businesses, to 
help assist in developing tailored, culturally informed, and community-supported 
messages. 
Conclusion 
The purpose of this quantitative study was to explore the relationship between the 
use of HPV vaccination and personal history of HPV, reduced access to healthcare, and 
risky sexual behaviors among African American women ages 18–49 in the United States.  
While this study found that no associations existed overall, age was statistically 
significant.  Women between the ages of 18 and 34 were 7.22 times as likely to receive 
the HPV vaccine compared to women aged 35–49 years (OR: 7.22; 95% CI: 2.36 – 
22.13).  Thus, women who are in late adolescence and early adulthood are more likely to 
be vaccinated.  Not only is it important that these groups be continuously targeted for 
HPV and cervical cancer prevention, but it is important that these groups of women assist 
in educating middle-aged women and mothers or caregivers of children to receive the 
HPV vaccine as well. 
It is important to continue researching this topic and make political and practical 
recommendations to prevent cervical cancer among African American women.  Given the 
promising scientific, medical, and technological advances in the prevention and early 
detection of cervical cancer in the United States, disparities in the use of these resources 
is concerning and is a reflection of a number of inadequacies in the country’s health 
system.  Given the ability to largely eradicate cervical cancer, the blatant racial disparities 
in prevalence and mortality rates are inexcusable and need to be addressed with urgency.  
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Future studies that integrate health belief modeling and drivers of health behavior may be 
of benefit on this issue, specifically in African American women.  This will allow for a 
better understanding of the health behaviors, knowledge, and other factors that are 
placing African American women at the forefront of HPV infection and cervical cancer 
mortality.  Public health education programs and interventions that focus on improving 
knowledge of HPV, cervical cancer, and HPV vaccination in adult African American 
women are necessary as a step towards positive social change in our world.   
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